Cassava Sciences Inc (SAVA)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SAVA market cap is 99.04M. The company's latest EPS is USD -1.4104 and P/E is -0.02.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.93M | -61.65M | -30.62M | -29.49M | -24.59M |
| Net Income | -18.75M | 49.95M | -27.94M | -71.39M | -23.4M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.79M | -32.87M | -80.02M | -105.96M | -141.45M |
| Net Income | -6.33M | -32.39M | -76.25M | -97.22M | -68.14M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 155.72M | 243.57M | 223.75M | 157.53M | 140.93M |
| Total Liabilities | 77.12M | 54.59M | 57.11M | 11.83M | 13.32M |
| Total Equity | 78.6M | 188.97M | 166.64M | 145.7M | 127.62M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 94.3M | 266.78M | 234.83M | 151.66M | 157.53M |
| Total Liabilities | 2.1M | 12.87M | 7.3M | 14.2M | 11.83M |
| Total Equity | 92.2M | 253.92M | 227.54M | 137.47M | 145.7M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.13M | -37.37M | -55.66M | -116.93M | -11.34M |
| Investing | N/A | -29k | -46k | -103k | N/A |
| Financing | 22.16M | 123.55M | 123.55M | 124.47M | 90k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.38M | -30.2M | -77.51M | -82.03M | -116.93M |
| Investing | 360k | -22.21M | -2.71M | -414k | -103k |
| Financing | 75.45M | 192.34M | 47.8M | 2.56M | 124.47M |
| Market Cap | 99.04M |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.01 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 48.31M |
| Average Volume (1 week) | 935.98k |
| Average Volume (1 Month) | 1.14M |
| 52 Week Change | -79.90% |
| 52 Week High | 42.20 |
| 52 Week Low | 1.15 |
| Spread (Intraday) | 0.01 (0.49%) |
| Company Name | Cassava Sciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.cassavasciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
